DK3585892T3 - Fremgangsmåder til oprensning af messenger-rna - Google Patents

Fremgangsmåder til oprensning af messenger-rna Download PDF

Info

Publication number
DK3585892T3
DK3585892T3 DK18711737.9T DK18711737T DK3585892T3 DK 3585892 T3 DK3585892 T3 DK 3585892T3 DK 18711737 T DK18711737 T DK 18711737T DK 3585892 T3 DK3585892 T3 DK 3585892T3
Authority
DK
Denmark
Prior art keywords
purification
methods
messenger rna
messenger
rna
Prior art date
Application number
DK18711737.9T
Other languages
English (en)
Inventor
Frank Derosa
Michael Heartlein
Jonathan Abysalh
Shrirang Karve
Anusha Dias
Daniel Crawford
Original Assignee
Translate Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translate Bio Inc filed Critical Translate Bio Inc
Application granted granted Critical
Publication of DK3585892T3 publication Critical patent/DK3585892T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y201/00—Transferases transferring one-carbon groups (2.1)
    • C12Y201/03—Carboxy- and carbamoyltransferases (2.1.3)
    • C12Y201/03003—Ornithine carbamoyltransferase (2.1.3.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK18711737.9T 2017-02-27 2018-02-27 Fremgangsmåder til oprensning af messenger-rna DK3585892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762463981P 2017-02-27 2017-02-27
PCT/US2018/019978 WO2018157141A1 (en) 2017-02-27 2018-02-27 Methods for purification of messenger rna

Publications (1)

Publication Number Publication Date
DK3585892T3 true DK3585892T3 (da) 2022-08-22

Family

ID=61683899

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18711737.9T DK3585892T3 (da) 2017-02-27 2018-02-27 Fremgangsmåder til oprensning af messenger-rna

Country Status (10)

Country Link
US (3) US10975369B2 (da)
EP (2) EP4008783A1 (da)
AU (1) AU2018224318B2 (da)
CA (1) CA3054323A1 (da)
DK (1) DK3585892T3 (da)
ES (1) ES2925083T3 (da)
HU (1) HUE059594T2 (da)
IL (1) IL268856B2 (da)
MA (1) MA47606A (da)
WO (1) WO2018157141A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4074693A1 (en) 2011-06-08 2022-10-19 Translate Bio, Inc. Cleavable lipids
IL268856B2 (en) * 2017-02-27 2024-09-01 Translate Bio Inc Methods for purification of messenger rna
WO2019036685A1 (en) 2017-08-18 2019-02-21 Modernatx, Inc. METHODS FOR HPLC ANALYSIS
EP3714048B1 (en) 2017-11-22 2025-04-09 ModernaTX, Inc. Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
EP3793689A1 (en) * 2018-05-15 2021-03-24 Translate Bio, Inc. Subcutaneous delivery of messenger rna
US11174500B2 (en) 2018-08-24 2021-11-16 Translate Bio, Inc. Methods for purification of messenger RNA
WO2020165158A1 (en) * 2019-02-11 2020-08-20 Ethris Gmbh Mrna purification by tangential flow filtration
WO2020168466A1 (en) 2019-02-19 2020-08-27 Stemirna Therapeutics Co., Ltd. Modified nucleoside and synthetic methods thereof
MX2021011031A (es) 2019-03-11 2021-12-10 Modernatx Inc Proceso de transcripción in vitro en lotes alimentados.
JP2023508881A (ja) 2019-12-20 2023-03-06 トランスレイト バイオ, インコーポレイテッド Mrna担持脂質ナノ粒子を調製する改善されたプロセス
MX2022007756A (es) 2019-12-20 2022-09-27 Translate Bio Inc Suministro rectal de arn mensajero.
CA3170319A1 (en) * 2020-02-10 2021-08-19 Translate Bio, Inc. Methods and compositions for messenger rna purification
CN115427021A (zh) 2020-02-25 2022-12-02 翻译生物公司 制备负载mrna的脂质纳米颗粒的改进方法
WO2021226468A1 (en) 2020-05-07 2021-11-11 Translate Bio, Inc. Improved compositions for cftr mrna therapy
WO2021226461A1 (en) * 2020-05-07 2021-11-11 Translate Bio, Inc. Generation of optimized nucleotide sequences
WO2021226463A1 (en) 2020-05-07 2021-11-11 Translate Bio, Inc. Composition and methods for treatment of primary ciliary dyskinesia
AU2021269042A1 (en) 2020-05-07 2023-02-02 Translate Bio, Inc. Optimized nucleotide sequences encoding SARS-CoV-2 antigens
JP7873638B2 (ja) * 2020-05-15 2026-06-12 トランスレイト バイオ, インコーポレイテッド mRNA送達のための脂質ナノ粒子製剤
EP4222258A2 (en) 2020-10-01 2023-08-09 Translate Bio, Inc. Methods for purification of messenger rna
CA3194863A1 (en) 2020-10-06 2022-04-14 Shrirang KARVE Improved process and formulation of lipid nanoparticles
CA3198411A1 (en) 2020-10-12 2022-04-21 Translate Bio, Inc. Improved process of preparing mrna-loaded lipid nanoparticles
US12678406B2 (en) 2020-10-12 2026-07-14 Translate Bio Inc. Process of preparing ice-based lipid nanoparticles
MX2023004371A (es) 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
CN116438298A (zh) 2020-10-15 2023-07-14 翻译生物公司 信使rna的大规模合成
US12576030B2 (en) 2020-11-09 2026-03-17 Translate Bio, Inc. Compositions for delivery of codon-optimized mRNA
US20250268994A1 (en) 2021-03-25 2025-08-28 Translate Bio, Inc. Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof
CA3215606A1 (en) 2021-04-19 2022-10-27 Shrirang KARVE Improved compositions for delivery of mrna
US20240277872A1 (en) 2021-05-12 2024-08-22 The Broad Institute, Inc. Modified mrna, modified non-coding rna, and uses thereof
US20220363937A1 (en) 2021-05-14 2022-11-17 Armstrong World Industries, Inc. Stabilization of antimicrobial coatings
EP4362920A1 (en) 2021-07-01 2024-05-08 Translate Bio, Inc. Compositions for delivery of mrna
JP2024545572A (ja) 2021-11-10 2024-12-10 トランスレイト バイオ, インコーポレイテッド 原発性線毛機能不全の治療のための組成物及び方法
EP4453238A1 (en) * 2021-12-23 2024-10-30 Quantoom Biosciences S.A. Methods and systems for capping nucleic acid molecules
BE1030203B1 (fr) * 2022-01-20 2023-08-21 Quantoom Biosciences S A Méthodes et systèmes de coiffage de molécules d’acide nucléique
BE1030204B1 (fr) * 2022-01-20 2023-08-21 Quantoom Biosciences S A Méthodes et systèmes de coiffage de molécules d’acide nucléique
WO2023118571A1 (en) * 2021-12-23 2023-06-29 Quantoom Biosciences S.A. Methods and systems for capping nucleic acid
JP2025506416A (ja) * 2022-02-03 2025-03-11 モデルナティエックス インコーポレイテッド mRNA精製のための連続的沈殿
EP4525830A1 (en) * 2022-05-17 2025-03-26 ModernaTX, Inc. Preparation of highly concentrated mrna
AU2023316794A1 (en) 2022-07-29 2025-03-13 Sanofi Pasteur Inc. Methods for ethanol-free mrna purification
WO2024083345A1 (en) 2022-10-21 2024-04-25 BioNTech SE Methods and uses associated with liquid compositions
EP4622630A1 (en) 2022-11-21 2025-10-01 Translate Bio, Inc. Compositions of dry powder formulations of messenger rna and methods of use thereof
AU2023394992A1 (en) 2022-12-15 2025-07-31 Sanofi Pasteur Inc. Mrna encoding influenza virus-like particle
TW202438514A (zh) 2022-12-20 2024-10-01 法商賽諾菲公司 鼻病毒mrna疫苗
JP2026503216A (ja) 2022-12-23 2026-01-28 サノフィ パスツール インコーポレイテッド メッセンジャーrnaの最適化されたテーリング
JP2026508405A (ja) 2023-03-07 2026-03-10 サノフィ パスツール インコーポレイテッド Kp34ポリメラーゼを用いたメッセンジャーrnaの製造
WO2024194767A1 (en) 2023-03-17 2024-09-26 BioNTech SE Automated drug production system
MX2025012337A (es) 2023-04-17 2026-02-03 Sanofi Pasteur Inc Formulaciones de polvo seco reconstituibles y métodos de uso de las mismas
WO2025017151A1 (en) 2023-07-18 2025-01-23 Sanofi Stable poly(a)-encoding messenger rna templates
WO2025104351A1 (en) 2023-11-17 2025-05-22 Sanofi Pasteur Inc. Hplc-based assays for detecting multiple mrna constructs
GB202319423D0 (en) * 2023-12-18 2024-01-31 BioNTech SE Measuring and reducing protein impurities
AU2024413535A1 (en) 2023-12-29 2026-08-13 Sanofi Vaccines US Inc. Modified rna polymerases
WO2025208142A2 (en) 2024-03-29 2025-10-02 New England Biolabs, Inc. Compositions, kits, and methods for in vitro transcription
WO2026033123A1 (en) 2024-08-08 2026-02-12 Sanofi Pasteur Inc. Lipid nanoparticle formulations for mrna delivery
WO2026093322A1 (en) 2024-10-28 2026-05-07 Sanofi Pasteur Inc. Improved dna constructs for manufacturing messenger rna by in vitro transcription
WO2026136725A2 (en) 2024-12-20 2026-06-25 Aera Therapeutics, Inc. Improved poly(a) tails for mrna and non-coding rna, and uses thereof

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1292758A (en) 1918-04-12 1919-01-28 Roque Galguera Y Gonzalez Filtering apparatus.
US1478660A (en) 1921-01-20 1923-12-25 Barnes Gerard Charles Centrifugal separator
NL296242A (da) 1962-10-01
US3411631A (en) 1966-09-09 1968-11-19 Dorr Oliver Inc Screening centrifuges
DE1632291B1 (de) 1966-10-22 1971-07-29 Hitachi Shipbuilding Eng Co Kontinuierlich arbeitende Siebzentrifuge
US3438500A (en) 1967-05-18 1969-04-15 Francisco A Pico Centrifugal separating apparatus
US3491888A (en) 1968-12-27 1970-01-27 Universal Oil Prod Co Self-cleaning screen baskets
DE1911147A1 (de) 1969-03-05 1970-11-19 Ernst Heinkel Maschb Gmbh Zentrifuge
US3483991A (en) 1969-05-07 1969-12-16 Pennwalt Corp Screen centrifuge apparatus
US3684099A (en) 1970-07-21 1972-08-15 Carl T Kiebach Assembly element for press
DE2153901C3 (de) 1971-10-28 1979-12-20 Elfo Ag Sachseln, Sachseln (Schweiz) Siebformkörper
US3774769A (en) 1971-11-22 1973-11-27 Gaf Corp Liquid filter pressurized apparatus
DE2709894C3 (de) 1977-03-08 1982-01-07 Heinkel Industriezentrifugen GmbH & Co, 7120 Bietigheim-Bissingen Diskontinuierliche Filterzentrifuge
DE2710624C2 (de) 1977-03-11 1985-09-19 Heinkel Industriezentrifugen GmbH + Co, 7120 Bietigheim-Bissingen Stülpfilterzentrifuge
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4381236A (en) 1981-02-19 1983-04-26 Baker Perkins Inc. High pressure rotary centrifugal separator having apparatus for automatically cyclically reciprocating a corotating separator basket scraper
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US4944874A (en) 1986-12-12 1990-07-31 Kabushiki Kaisha Okawara Seisakusho Centrifugal separator
DE3740411C2 (de) 1987-11-28 1996-11-14 Heinkel Ind Zentrifugen Stülpfilterzentrifuge
DE3838108A1 (de) 1988-11-10 1990-05-17 Heinkel Ind Zentrifugen Vorrichtung zum betreiben eines auspressfilters
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
DE3916383C2 (de) 1989-05-19 1999-01-07 Guntram Krettek Vorrichtung zum Halten von Filterfolien oder Filtertüchern
US5004540A (en) 1989-12-01 1991-04-02 Ketema Process Equipment Division Invertible filter-type centrifuge with improved bearing and seal assembly
US20070053879A1 (en) * 1990-03-05 2007-03-08 Genzyme Corporation Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
US5277804A (en) 1990-03-24 1994-01-11 Heinkel Industriezentrifugen Gmbh & Co. Sleeve filter centrifuge
DE59007695D1 (de) 1990-03-24 1994-12-15 Heinkel Ind Zentrifugen Stülpfilterzentrifuge.
SE9003978D0 (sv) * 1990-12-13 1990-12-13 Henrik Garoff Dna expressionssystem baserade paa ett virus replikon
EP0584289B1 (de) 1991-05-04 1996-09-11 Heinkel Industriezentrifugen Gmbh & Co. Stülpfilter-zentrifuge
DE4230261A1 (de) 1991-10-01 1993-04-08 Krauss Maffei Ag Diskontinuierlich arbeitende filterzentrifuge
US5378364A (en) 1992-09-14 1995-01-03 Baker Hughes Incorporated Conical screen basket centrifuge
US5571669A (en) * 1993-01-14 1996-11-05 The University Of Pennsylvania Transcription and nucleic acid sequence determination with short primer DNA/RNA molecules and RNA polymerase
US5380434A (en) 1993-07-21 1995-01-10 Tema Systems, Inc. Centrifuge scroll with abrasion resistant inserts
DE59308079D1 (de) 1993-07-22 1998-03-05 Escher Wyss Ag Doppelschubzentrifuge
US5397471A (en) 1993-08-30 1995-03-14 Tema Systems, Inc. Self-cleaning scroll and screen centrifuge
US5433849A (en) 1993-09-15 1995-07-18 Lyco Manufacturing, Inc. Double drum waste water screen
DE4337618C1 (de) 1993-11-04 1995-02-16 Krauss Maffei Ag Stülpfilterzentrifuge (Trommelraumabdichtung)
EP0743950B1 (de) * 1994-02-11 2001-12-12 QIAGEN GmbH Verfahren zur trennung von doppelstrang/einzelstrangnukleinsäurestrukturen
AU2215995A (en) * 1994-04-07 1995-10-30 Akzo Nobel N.V. Freeze-dried compositions comprising rna
US6291189B1 (en) * 1994-05-10 2001-09-18 Carta Proteomics, Inc. Methods for the high-resolution identification of solvent-accessible amide hydrogens in polypeptides or proteins and for characterization of the fine structure of protein binding sites
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US5713826A (en) 1996-05-07 1998-02-03 Waterlink, Inc. Vertical basket centrifuge with feed acceleration and a removable liner
US5874268A (en) * 1996-09-23 1999-02-23 Duke University Method of introducing exogenous compounds into cells by electroporation and apparatus for same
IT1285052B1 (it) 1996-10-18 1998-06-03 Gennaretti S P A Centrifuga orizzontale per l'estrazione di olio da un impasto oleoso
EP1021549A2 (en) * 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
US7087580B2 (en) * 1998-04-23 2006-08-08 Genesense Technologies, Inc. Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
US6811788B2 (en) * 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
EP1326844A2 (en) * 2000-10-16 2003-07-16 Chugai Seiyaku Kabushiki Kaisha Process for preparation of n-substituted 2-sulfanylimidazoles
DE10115381A1 (de) 2001-03-28 2002-10-24 Heinkel Ag Stülpfilterzentrifuge
US7348418B2 (en) * 2002-02-08 2008-03-25 Memorial Sloan-Kettering Cancer Center Carcinoma-related genes and polypeptides and methods of use thereof
US6736968B2 (en) 2002-06-25 2004-05-18 Tema Systems, Inc. Horizontal scroll screen centrifuge
DE60334460D1 (de) * 2002-08-14 2010-11-18 Mitsubishi Chem Medience Corp Antikörper spezifisch für das tau-protein des zentralen nervensystems
DE10245013A1 (de) 2002-09-20 2004-04-01 Heinkel Aktiengesellschaft Filterzentrifuge
DE10311997A1 (de) 2003-03-19 2004-10-07 Johannes Gerteis Stülpfilterzentrifuge
US20050048045A1 (en) * 2003-07-02 2005-03-03 Board Of Regents, The University Of Texas System Regulation of urokinase receptor expression by phosphoglycerate kinase
WO2005093052A1 (en) * 2004-03-26 2005-10-06 Fuji Photo Film Co., Ltd. Method for selectively separating and purifying rna and method for separating and purifying nucleic acid
US20050245381A1 (en) 2004-04-30 2005-11-03 National-Oilwell, L.P. Centrifuge accelerator system
DE102004032460B3 (de) * 2004-06-30 2005-08-18 Rina-Netzwerk Rna Technologien Gmbh Verfahren zur präparativen in vitro Proteinbiosynthese
FR2873596B1 (fr) 2004-07-27 2006-09-22 Weatherford Lamb Centrifugeuse avec une bride de serrage crantee
EP1838353A2 (en) * 2005-01-21 2007-10-03 Introgen Therapeutics, Inc. Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
US20080149558A1 (en) 2006-12-21 2008-06-26 Ferrum Ag Centrifuge drum
WO2008122067A1 (en) 2007-04-05 2008-10-16 Ludowici Mineral Processing Equipment Pty Ltd Centrifugal scroll screen apparatus
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
US8021289B2 (en) 2009-02-20 2011-09-20 Tema Systems, Inc. Clean-in-place decanter centrifuge
US20100326827A1 (en) * 2009-06-24 2010-12-30 Shang-Chi Lin Method and apparatus for isolating and purifying bio-molecules
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
WO2011063519A1 (en) 2009-11-27 2011-06-03 Arrowcorp Inc. Cylinder exchange device and method for solid material processor
SI2506857T1 (en) 2009-12-01 2018-08-31 Translate Bio, Inc. Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
US8853377B2 (en) * 2010-11-30 2014-10-07 Shire Human Genetic Therapies, Inc. mRNA for use in treatment of human genetic diseases
KR20220025112A (ko) * 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
EP4074693A1 (en) 2011-06-08 2022-10-19 Translate Bio, Inc. Cleavable lipids
US9512073B2 (en) 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
EP2791159A4 (en) * 2011-12-14 2015-10-14 Moderna Therapeutics Inc MODIFIED NUCLEIC ACIDS AND ACUTE TREATMENT USES THEREOF
ES2923757T3 (es) * 2011-12-16 2022-09-30 Modernatx Inc Composiciones de ARNm modificado
WO2013151664A1 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
US9933343B2 (en) * 2012-03-14 2018-04-03 Chromologic Llc Integrated membrane for preservation of biomolecules
BR112014024131A2 (pt) 2012-03-29 2017-07-25 Shire Human Genetic Therapies lipídios catiônicos ionizáveis
HK1206644A1 (en) 2012-03-29 2016-01-15 Shire Human Genetic Therapies, Inc. Lipid-derived neutral nanoparticles
US10501513B2 (en) * 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides for the production of oncology-related proteins and peptides
EA201492055A1 (ru) 2012-06-08 2015-11-30 Шир Хьюман Дженетик Терапис, Инк. ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
EP3536787A1 (en) 2012-06-08 2019-09-11 Translate Bio, Inc. Nuclease resistant polynucleotides and uses thereof
WO2014043541A1 (en) 2012-09-14 2014-03-20 Bilfinger Water Technologies, Inc. Variable geometry centrifugal basket
US20150366997A1 (en) 2012-12-07 2015-12-24 Shire Human Genetics Therapies, Inc. COMPOSITIONS AND METHODS FOR mRNA DELIVERY
WO2014152940A1 (en) 2013-03-14 2014-09-25 Shire Human Genetic Therapies, Inc. Mrna therapeutic compositions and use to treat diseases and disorders
EA201591283A1 (ru) 2013-03-14 2016-02-29 Шир Хьюман Дженетик Терапис, Инк. Количественная оценка эффективности кэп матричной рнк
EP3932947A1 (en) 2013-03-14 2022-01-05 Translate Bio MA, Inc. Methods and compositions for delivering mrna coded antibodies
US10258698B2 (en) * 2013-03-14 2019-04-16 Modernatx, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
KR102311614B1 (ko) 2013-03-14 2021-10-08 샤이어 휴먼 지네틱 테라피즈 인크. Cftr mrna 조성물 및 관련 방법 및 사용
US10266559B2 (en) 2013-03-14 2019-04-23 Translate Bio, Inc. Ribonucleic acids with 4′-thio-modified nucleotides and related methods
EA201591229A1 (ru) 2013-03-14 2016-01-29 Шир Хьюман Дженетик Терапис, Инк. Способы очистки матричной рнк
MX2015011945A (es) 2013-03-14 2015-12-01 Shire Human Genetic Therapies Evaluacion cuantitativa para la eficacia de los casquetes de arn mensajero.
WO2014144767A1 (en) * 2013-03-15 2014-09-18 Moderna Therapeutics, Inc. Ion exchange purification of mrna
CN104236289B (zh) 2013-06-06 2016-03-23 富泰华工业(深圳)有限公司 脱水装置
ES3032935T3 (en) 2013-10-22 2025-07-29 Translate Bio Inc Lipid formulations for delivery of messenger rna
ES2707966T3 (es) 2013-10-22 2019-04-08 Translate Bio Inc Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
EP3574923A1 (en) 2013-10-22 2019-12-04 Translate Bio, Inc. Mrna therapy for phenylketonuria
AU2014340149B2 (en) 2013-10-22 2020-12-24 Shire Human Genetic Therapies, Inc. CNS delivery of mRNA and uses thereof
US9534214B2 (en) * 2013-10-31 2017-01-03 General Electric Company Substrates and associated methods for elution of nucleic acids
JP2017507946A (ja) * 2014-02-26 2017-03-23 エスリス ゲーエムベーハーethris GmbH Rnaを胃腸内投与するための組成物
PL3122878T3 (pl) 2014-03-24 2019-06-28 Translate Bio, Inc. TERAPIA mRNA DO LECZENIA CHORÓB OCZU
EP4729528A3 (en) * 2014-04-25 2026-06-24 Translate Bio, Inc. Methods for purification of messenger rna
WO2015184256A2 (en) 2014-05-30 2015-12-03 Shire Human Genetic Therapies, Inc. Biodegradable lipids for delivery of nucleic acids
KR102559979B1 (ko) 2014-06-24 2023-07-25 샤이어 휴먼 지네틱 테라피즈 인크. 핵산의 전달용 입체화학적으로 풍부한 조성물
WO2016004318A1 (en) 2014-07-02 2016-01-07 Shire Human Genetic Therapies, Inc. Encapsulation of messenger rna
EP3177732A4 (en) * 2014-08-08 2018-04-25 ModernaTX, Inc. Compositions and methods for the treatment of ophthalmic diseases and conditions
CN106999957B (zh) 2014-08-14 2020-11-03 阿奎塞腾斯集团有限公司 分批式离心机过滤网
DE102014119605A1 (de) 2014-12-23 2016-06-23 Andritz Kmpt Gmbh Filterzentrifuge
WO2016112428A1 (en) 2015-01-15 2016-07-21 Weir Minerals Australia Ltd Centrifugal scroll screen apparatus
CN107427843B (zh) 2015-01-15 2019-10-25 伟尔矿物澳大利亚私人有限公司 离心式涡旋筛分装置
WO2016112426A1 (en) 2015-01-15 2016-07-21 Weir Minerals Australia Ltd Centrifugal screening apparatus
EP3270894B1 (en) 2015-03-19 2021-02-24 Translate Bio, Inc. Mrna therapy for pompe disease
DK3303583T3 (da) * 2015-05-29 2020-07-13 Curevac Real Estate Gmbh Fremgangsmåde til fremstilling og oprensning af rna, omfattende mindst et trin til tangential-flow-filtrering
US10501768B2 (en) * 2015-07-13 2019-12-10 Curevac Ag Method of producing RNA from circular DNA and corresponding template DNA
EP4101930A1 (en) * 2015-09-17 2022-12-14 ModernaTX, Inc. Polynucleotides containing a stabilizing tail region
US20190054112A1 (en) * 2015-09-18 2019-02-21 Moderna Therapeutics, Inc. Polynucleotide formulations for use in the treatment of renal diseases
IL268856B2 (en) * 2017-02-27 2024-09-01 Translate Bio Inc Methods for purification of messenger rna

Also Published As

Publication number Publication date
US20210180041A1 (en) 2021-06-17
EP3585892B8 (en) 2022-07-13
IL268856A (en) 2019-10-31
CA3054323A1 (en) 2018-08-30
US12410422B2 (en) 2025-09-09
IL268856B1 (en) 2024-05-01
US20260049299A1 (en) 2026-02-19
HUE059594T2 (hu) 2022-11-28
EP3585892A1 (en) 2020-01-01
IL268856B2 (en) 2024-09-01
EP3585892B1 (en) 2022-06-01
MA47606A (fr) 2021-04-07
AU2018224318A1 (en) 2019-09-19
AU2018224318B2 (en) 2024-06-20
WO2018157141A1 (en) 2018-08-30
ES2925083T3 (es) 2022-10-13
US10975369B2 (en) 2021-04-13
US20180251754A1 (en) 2018-09-06
EP4008783A1 (en) 2022-06-08

Similar Documents

Publication Publication Date Title
DK3585891T3 (da) Fremgangsmåder til oprensning af messenger-rna
DK3636742T3 (da) Fremgangsmåder til oprensning af messenger-rna
HUE059594T2 (hu) Hírvivõ RNS tisztítására szolgáló eljárások
DK3585886T5 (da) Storskalasyntese af messenger-rna
DK4140491T5 (da) Fremgangsmåde til syntetisering af RNA'er med 5'-kappe
DK3467108T3 (da) Fremgangsmåder til oprensning af messenger-RNA
IL263690A (en) Purification of multispecific antibodies
DK3268390T3 (da) Fremgangsmåder til oprensning af bispecifikke antistoffer
DK3445850T3 (da) Fremgangsmåder til tilvejebringelse af enkeltstrenget rna
DK3377059T3 (da) Hæmmere af cxcr2
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3337902T3 (da) 3'-utr-sekvenser til stabilisering af rna
EP3349649A4 (en) NAVIGATION OF TUBULAR NETWORKS
DK3294885T3 (da) Fremgangsmåde til at fremstille rna
DK3463483T3 (da) Behandling af primær ciliedyskinesi med syntetisk messenger-RNA
DK3607068T3 (da) RNA-interferensmedieret inhibering af TMPRSS6
LT3116891T (lt) Imunoglobulino gryninimas, naudojant išankstinio valymo pakopas
DK3201361T3 (da) Fremgangsmåder til kvantificering af cellefrit DNA
DK3113858T3 (da) Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater
DK3609529T3 (da) Rna til behandling af autoimmune sygdomme
DK3510042T3 (da) Fremgangsmåde til rensning af antistoffer
DK3665173T3 (da) Ny fremgangsmåde til yntetisering af amanitiner
DK3680000T3 (da) Fremgangsmåder til oprensning af antistoffer
PL3268391T3 (pl) Sposoby zmniejszania poziomów środków zawierających Fc w surowicy z zastosowaniem antagonistów FcRn
DK3347481T3 (da) Fremgangsmåde til oprensning af biomassehydrolysat